Determining the specificity of vesicle traffic at the Golgi apparatus

确定高尔基体囊泡运输的特异性

基本信息

  • 批准号:
    BB/X006859/1
  • 负责人:
  • 金额:
    $ 69.27万
  • 依托单位:
  • 依托单位国家:
    英国
  • 项目类别:
    Research Grant
  • 财政年份:
    2023
  • 资助国家:
    英国
  • 起止时间:
    2023 至 无数据
  • 项目状态:
    未结题

项目摘要

The cells that make up our organs and tissues are comprised of internal compartments, called organelles, that have distinct compositions and functions. Most organelles contain fat-like molecules called lipids that make a limiting membrane to separate the organelle contents from the rest of the cell, as well as many types of proteins. The function of organelles requires the delivery of new materials and the exchange of materials with other organelles in the cell. Transport of proteins and lipids between organelles is mediated by small spherical carriers called vesicles, which bud off one compartment and bind to and fuse with their destination compartment to deliver their contents. This process, which is conserved in all plants and animals, is essential for life, and when defective can result in a large number of diseases in humans. It is also exploited by pathogenic bacteria and viruses during their life cycle. Vesicle transport is highly specific, such that vesicles are recognized at the destination compartment in a selective manner, which ensures they deliver their contents to the correct place. Although vesicle transport has been studied for decades, we still lack a good understanding of how vesicle recognition occurs.The Golgi apparatus is a major transport hub in the cell. It receives vesicles from other organelles, and also moves cargo between its own sub-compartments in vesicles. Its major function is to sort cargo for distribution, and to modify it so it matures correctly. Vesicle recognition at the Golgi is mediated by long proteins called golgins, which are act like tentacles to capture, or tether, vesicles at their ends. Previous work has shown that golgins act in a selective manner to tether vesicles, thereby contributing to the specificity of vesicle transport at the Golgi. However, what they recognise on vesicles is not known. It is also not known whether the golgins have overlapping specificity in vesicle recognition. This study will address these outstanding questions, focussing on the golgins that mediate transport within the Golgi, which is critical for the function of this organelle. Our preliminary data suggests that lipids on the vesicle surface dictate the specificity of vesicle transport at the Golgi through selective recognition by the golgins. To test this hypothesis, we will investigate the lipid binding specificity of the golgins, using purified lipid vesicles and golgins, combined with unbiased lipid identification techniques, and determine the features of the golgins that bind to lipids. Subsequently, we will determine the importance of golgin-vesicle lipid interaction in the transport and modification of cargo proteins at the Golgi apparatus. This will be achieved using gene editing techniques to alter the golgins so they can no longer bind vesicle lipids, and effects upon cargo transport assessed using established assays. Cargo modification will be also assessed using established methods to measure the amount and composition of sugars added to the cargo proteins in the Golgi, which is highly dependent on vesicle transport rates at this organelle. To assess the importance of golgin binding to vesicle lipids in a more physiological context, we will perform similar experiments in the nematode worm C. elegans. Effects upon development, viability, tissue formation and function, and ageing, will be assessed alongside analysis of the Golgi in different cell types. Because of the genetic tractability of this model, we will also be able to knock-out or modify the golgins in different combinations to assess the extent of overlapping specificity and functional redundancy between these proteins, and hence of vesicle transport at the Golgi. The work will be important for our understanding of vesicle transport, and specifically in how the specificity of vesicle transport is achieved, which represents a major unanswered question in the field.
构成我们器官和组织的细胞由称为细胞器的内部隔室组成,它们具有不同的组成和功能。大多数细胞器含有称为脂质的脂肪样分子,它们形成限制膜,将细胞器内容物与细胞的其余部分以及许多类型的蛋白质分开。细胞器的功能需要输送新物质以及与细胞内其他细胞器进行物质交换。细胞器之间蛋白质和脂质的运输是由称为囊泡的小型球形载体介导的,囊泡从一个隔室中萌芽,并与其目的地隔室结合并融合以输送其内容物。这一过程在所有植物和动物中都是保守的,对于生命至关重要,如果出现缺陷,可能会导致人类出现大量疾病。病原细菌和病毒在其生命周期中也会利用它。囊泡运输具有高度特异性,因此囊泡在目的地隔间以选择性方式被识别,这确保它们将其内容物递送到正确的位置。尽管囊泡运输已经研究了几十年,但我们仍然对囊泡识别如何发生缺乏充分的了解。高尔基体是细胞中的主要运输枢纽。它从其他细胞器接收囊泡,并在囊泡中自己的子区室之间移动货物。它的主要功能是对货物进行分类以进行分配,并对其进行修改以使其正确成熟。高尔基体的囊泡识别是由称为高尔基蛋白的长蛋白介导的,它们的作用就像触手一样,在其末端捕获或束缚囊泡。先前的研究表明,高尔金以选择性的方式束缚囊泡,从而有助于高尔基体囊泡运输的特异性。然而,它们在囊泡上识别的内容尚不清楚。也不知道高尔金斯在囊泡识别中是否具有重叠的特异性。这项研究将解决这些悬而未决的问题,重点关注介导高尔基体内运输的高尔金斯,这对于该细胞器的功能至关重要。我们的初步数据表明,囊泡表面的脂质通过高尔金的选择性识别决定了高尔基体囊泡运输的特异性。为了检验这一假设,我们将使用纯化的脂质囊泡和高尔金斯,结合无偏脂质鉴定技术,研究高尔金斯的脂质结合特异性,并确定与脂质结合的高尔金斯的特征。随后,我们将确定高尔金-囊泡脂质相互作用在高尔基体货物蛋白运输和修饰中的重要性。这将通过基因编辑技术改变高尔金斯来实现,使它们不再结合囊泡脂质,并使用已建立的测定法评估对货物运输的影响。还将使用已建立的方法来评估货物修饰,以测量添加到高尔基体货物蛋白中的糖的数量和成分,这高度依赖于该细胞器的囊泡运输速率。为了在更生理的背景下评估高尔金与囊泡脂质结合的重要性,我们将在线虫秀丽隐杆线虫中进行类似的实验。将评估对发育、活力、组织形成和功能以及衰老的影响,同时分析不同细胞类型的高尔基体。由于该模型的遗传易处理性,我们还能够以不同的组合敲除或修饰高尔金斯,以评估这些蛋白质之间重叠特异性和功能冗余的程度,从而评估高尔基体囊泡运输的程度。这项工作对于我们理解囊泡运输,特别是如何实现囊泡运输的特异性非常重要,这是该领域一个尚未解答的主要问题。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Martin Lowe其他文献

High prevalence of early repolarization in the pediatric relatives of Sudden Arrhythmic Death Syndrome (SADS) victims and in normal controls
心律失常性死亡综合症 (SADS) 患者的儿科亲属和正常对照中早期复极的发生率较高
  • DOI:
  • 发表时间:
    2018
  • 期刊:
  • 影响因子:
    0
  • 作者:
    A. McCorquodale;R. Poulton;J. Hendry;G. Norrish;E. Field;Sarah;Mead;Martin Lowe;J. Kaski
  • 通讯作者:
    J. Kaski
PO-04-149 strongAHEAD OF THE CURVE – EXPERIENCE FROM THE UK’S FIRST DEDICATED SPECIALIST CRM CLINIC FOR ACHD PATIENTS/strong
PO-04-149 领先于曲线——来自英国第一家专门为 ACHD 患者设立的专业 CRM 诊所的经验
  • DOI:
    10.1016/j.hrthm.2023.03.1273
  • 发表时间:
    2023-05-01
  • 期刊:
  • 影响因子:
    5.700
  • 作者:
    Holly L. Daw;Ciaran Goswell;Charles Butcher;Jeremy Kalindjian;Bruna C. Di Nubila;Vinit Sawhney;Martin Lowe;Filip R. Zemrak;Vivienne A. Ezzat
  • 通讯作者:
    Vivienne A. Ezzat
Glutamate Release from Guinea‐Pig Synaptosomes: Stimulation by Reuptake‐Induced Depolarization
豚鼠突触体中谷氨酸的释放:再摄取诱导的去极化的刺激
  • DOI:
    10.1111/j.1471-4159.1989.tb07296.x
  • 发表时间:
    1989
  • 期刊:
  • 影响因子:
    4.7
  • 作者:
    H. McMahon;A. Barrie;Martin Lowe;D. Nicholls
  • 通讯作者:
    D. Nicholls
PO-01-048 strongFACTORS INFLUENCING SUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATOR SCREENING SUCCESS IN PAEDIATRIC POPULATION: A TERTIARY HOSPITAL EXPERIENCE/strong
影响儿科人群皮下植入式心脏复律除颤器筛查成功的强因素:一家三级医院的经验
  • DOI:
    10.1016/j.hrthm.2023.03.697
  • 发表时间:
    2023-05-01
  • 期刊:
  • 影响因子:
    5.700
  • 作者:
    Alanna Morrison;Sophie Marshall;Stacey James;Charles Butcher;Eleanor Thompson;Martin Lowe;Jasveer S. Mangat;Abdualrahman Alkanhal
  • 通讯作者:
    Abdualrahman Alkanhal
Signalling for secretion
分泌信号
  • DOI:
    10.1038/ncb0905-851
  • 发表时间:
    2005-09-01
  • 期刊:
  • 影响因子:
    19.100
  • 作者:
    Yashoda Ghanekar;Martin Lowe
  • 通讯作者:
    Martin Lowe

Martin Lowe的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Martin Lowe', 18)}}的其他基金

Understanding and treating neurogenetic conditions related to the Kennedy pathway
了解和治疗与肯尼迪通路相关的神经遗传疾病
  • 批准号:
    MR/Y014251/1
  • 财政年份:
    2024
  • 资助金额:
    $ 69.27万
  • 项目类别:
    Research Grant
Coordination of membrane traffic in the early secretory pathway
早期分泌途径中膜运输的协调
  • 批准号:
    BB/S014799/1
  • 财政年份:
    2019
  • 资助金额:
    $ 69.27万
  • 项目类别:
    Research Grant
A new role for intermediate filaments in the secretory pathway
中间丝在分泌途径中的新作用
  • 批准号:
    BB/T000945/1
  • 财政年份:
    2019
  • 资助金额:
    $ 69.27万
  • 项目类别:
    Research Grant
Mechanisms of endocytic recycling in the renal proximal tubule
肾近曲小管内吞再循环机制
  • 批准号:
    BB/N000641/1
  • 财政年份:
    2016
  • 资助金额:
    $ 69.27万
  • 项目类别:
    Research Grant
Dissecting the function of GORAB, the protein mutated in Geroderma osteodysplastica
剖析 GORAB 的功能,GORAB 是骨发育不良中突变的蛋白质
  • 批准号:
    MR/N000366/1
  • 财政年份:
    2015
  • 资助金额:
    $ 69.27万
  • 项目类别:
    Research Grant
The role of OCRL1 in endocytic membrane traffic
OCRL1在内吞膜运输中的作用
  • 批准号:
    MR/K000810/1
  • 财政年份:
    2013
  • 资助金额:
    $ 69.27万
  • 项目类别:
    Research Grant
Dissecting the roles of ZFPL1 and GMAP210 in Golgi biogenesis and membrane traffic
剖析 ZFPL1 和 GMAP210 在高尔基体生物发生和膜运输中的作用
  • 批准号:
    BB/I007717/1
  • 财政年份:
    2011
  • 资助金额:
    $ 69.27万
  • 项目类别:
    Research Grant
A Manchester-Beijing Strategic Parntership in Molecular Life Sciences
曼彻斯特-北京分子生命科学战略合作伙伴关系
  • 批准号:
    BB/H531600/1
  • 财政年份:
    2010
  • 资助金额:
    $ 69.27万
  • 项目类别:
    Research Grant
Mitotic regulation of the Golgi apparatus- the role of the ARF nucleotide exchange factor GBF1
高尔基体的有丝分裂调节——ARF核苷酸交换因子GBF1的作用
  • 批准号:
    BB/F005628/1
  • 财政年份:
    2008
  • 资助金额:
    $ 69.27万
  • 项目类别:
    Research Grant
Molecular organisation of the secretory and endocytic pathways
分泌和内吞途径的分子组织
  • 批准号:
    G0501725/1
  • 财政年份:
    2006
  • 资助金额:
    $ 69.27万
  • 项目类别:
    Research Grant

相似国自然基金

背根神经节中Mrgprd通过一种特异性lncRNA调控阿片类药物耐受的外周机制研究
  • 批准号:
    82371224
  • 批准年份:
    2023
  • 资助金额:
    49.00 万元
  • 项目类别:
    面上项目
多盘科单殖吸虫宿主特异性及其与无尾两栖类宿主协同进化关系研究
  • 批准号:
    30960049
  • 批准年份:
    2009
  • 资助金额:
    23.0 万元
  • 项目类别:
    地区科学基金项目
Dyrk1A调控CaMKⅡδ的可变剪接及其在心脏重构过程中的作用
  • 批准号:
    30971223
  • 批准年份:
    2009
  • 资助金额:
    31.0 万元
  • 项目类别:
    面上项目

相似海外基金

Comparison of direct and indirect magnetic resonance imaging of myelin in Alzheimer's disease
阿尔茨海默病髓磷脂直接和间接磁共振成像的比较
  • 批准号:
    10680319
  • 财政年份:
    2023
  • 资助金额:
    $ 69.27万
  • 项目类别:
Molecular mechanism of membrane association of Bruton's Tyrosine Kinase
布鲁顿酪氨酸激酶膜缔合的分子机制
  • 批准号:
    10604872
  • 财政年份:
    2023
  • 资助金额:
    $ 69.27万
  • 项目类别:
Surface exosome integrin profiling to predict organotropic metastasis of breast cancer
表面外泌体整合素分析预测乳腺癌的器官转移
  • 批准号:
    10654221
  • 财政年份:
    2023
  • 资助金额:
    $ 69.27万
  • 项目类别:
Extracellular vesicles encapsulating CRISPR machinery for treatment of SARS-CoV-2 infection
封装 CRISPR 机制的细胞外囊泡用于治疗 SARS-CoV-2 感染
  • 批准号:
    10655147
  • 财政年份:
    2023
  • 资助金额:
    $ 69.27万
  • 项目类别:
Nanoscopic Membrane Modulations Induced by Nanoscale Oligomers
纳米级低聚物诱导的纳米膜调节
  • 批准号:
    10790511
  • 财政年份:
    2023
  • 资助金额:
    $ 69.27万
  • 项目类别:
Dual protease activated peptides for specific targeting
用于特异性靶向的双蛋白酶激活肽
  • 批准号:
    10680341
  • 财政年份:
    2023
  • 资助金额:
    $ 69.27万
  • 项目类别:
Affinity purification of cross-ß fibrils using immobilized thioflavin
使用固定化硫代黄素对交叉原纤维进行亲和纯化
  • 批准号:
    10646061
  • 财政年份:
    2023
  • 资助金额:
    $ 69.27万
  • 项目类别:
Increasing the Complexity of Microtubule-based transport: Cargo adaptors and Hitchhiking on Vesicles.
增加基于微管的运输的复杂性:货物适配器和囊泡搭便车。
  • 批准号:
    10713449
  • 财政年份:
    2023
  • 资助金额:
    $ 69.27万
  • 项目类别:
Targeting Cholinergic Deficits with Retinoic Acid after TBI
使用视黄酸治疗 TBI 后的胆碱能缺陷
  • 批准号:
    10741924
  • 财政年份:
    2023
  • 资助金额:
    $ 69.27万
  • 项目类别:
A nanosized magnetic particle system for fast and efficient neuronal extracellular vesicle enrichment from plasma
一种纳米磁性粒子系统,用于从血浆中快速有效地富集神经元细胞外囊泡
  • 批准号:
    10820640
  • 财政年份:
    2023
  • 资助金额:
    $ 69.27万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了